Tag: mounjaro

mounjaro

Latest News

Obesity drug smuggling on the rise as foreign markets offer lower prices

Seizures of GLP-1s at customs are surging as people chase deals abroad and critics fault the government for tougher enforcement without easing costs.

2026.6.23

Eli Lilly Korea to roll out high-dose Mounjaro, sharpening obesity-drug rivalry with Novo Nordisk

Eli Lilly Korea is launching higher-dose Mounjaro as competition with Novo Nordisk’s Wegovy intensifies in the country’s booming obesity drug market.

2026.6.9

Most popular

A notice announcing that the obesity treatment drug Mounjaro is sold out is posted at a clinic in Jongno District, central Seoul, on Aug. 25, 2025. [CHAE HYE-SEON]

Record high scrips for Mounjaro for weight loss raise concern that urgent medical cases will get left out

Monthly prescriptions of obesity and diabetes management drug Mounjaro have surpassed 200,000 for the first time in March, raising concerns that demand for the drug by people seeking to lose weight could limit access for other patients.

2026.4.16

A pharmacist displays a box of Mounjaro in Provo, Utah, on March 29, 2023. [REUTERS/YONHAP]

Regulators stepping in to stop rise of fake diet drugs from flooding the market

Counterfeit diet products that imitate the names and packaging of obesity drugs such as Mounjaro and Wegovy are spreading online. Regulators have stepped up enforcement as consumer confusion about which products are genuine continues to grow.

2026.2.23

Boxes of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes [LILLY KOREA]

Thirty-five cases of adverse reactions to Mounjaro reported in first month of availability

Thirty-five cases of adverse reactions or serious side effects were reported in Korea within the first month of the release of Mounjaro (tirzepatide), a weight loss drug developed by Eli Lilly.

2025.12.10

Stacks of direct-purchase parcels are seen at the express cargo logistics center of Incheon Airport Regional Customs in Jung District, Incheon, on Nov. 20. [NEWS1]

Koreans rush to reclaim Mounjaro orders stuck at customs

Korean customs officers have been grappling with an unexpected rush of travelers at Incheon International Airport, many hoping to reclaim seized packages of the weight-loss drug Mounjaro that they ordered from cheaper overseas sellers.

2025.11.20

A notice about Wegovy is seen posted at a pharmacy in Jongno District, central Seoul on Dec. 2, 2024. [YONHAP]

Government to designate Wegovy and Mounjaro as drugs of concern for misuse

The government plans to designate medications like Wegovy and Mounjaro as “drugs of concern for misuse,” citing widespread off-label use for cosmetic weight loss.

2025.10.27

A notice about Wegovy is seen at a pharmacy in Jongno District, central Seoul, on Dec. 2, 2024. [YONHAP]

Wegovy prescriptions near 400,000 as experts concerned over widespread use, health risks

Prescriptions for popular weight-loss drug Wegovy have soared in Korea, reaching nearly 400,000 just eight months after its launch. But doctors and health officials warn of reckless use far beyond the drug's approved purpose.

2025.8.25

A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Eli Lilly at Rock Canyon Pharmacy in Provo, Utah, on March 29, 2023. [REUTERS/YONHAP]

Korea's obesity drug market heats up as Mounjaro launches and Wegovy cuts price

Korea's obesity drug market, currently dominated by Wegovy, is bracing for a shake-up as Mounjaro, a drug with a more potent weight-loss effect, is set to be distributed in Korea from Wednesday.

2025.8.19

Eli Lilly's Mounjaro to land in Korea, setting off price war with Wegovy

Eli Lilly’s cut-price Mounjaro lands in Korea next week, ending Novo Nordisk’s domestic monopoly and igniting a price war in the weight loss drug market, while Wegovy will switch to tiered pricing in a global first.

2025.8.13